Clinical Trial: Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear(R)) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas

U.S., Aug. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07759817) titled 'Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear(R)) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas' on Aug. 04.

Brief Summary: This study evaluates the safety and effectiveness of the UltraClear(R) 2,910 nm fractional ablative fiber laser for improving skin laxity and tissue lifting in the lower face, submental, and neck areas. Up to 50 adults ages 35-65 will receive two laser treatments approximately 7 weeks apart at two clinical sites. Outcomes will be assessed approximately 90 days after the second treatment using photographic analysis and investiga...